![]() |
New MS drug with FDA approval--Briumvi (ublituximab)
This announcement from the MS Association of America (December 28, 2022) gives details about the latest FDA-approved MS drug, Briumvi (ublituximab):
FDA Approves Briumvi™ for the Treatment of Relapsing Forms of MS | MSAA |
All times are GMT -5. The time now is 06:38 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.